Literature DB >> 28487004

Longitudinal Trajectories of Informant-Reported Daily Functioning in Empirically Defined Subtypes of Mild Cognitive Impairment.

Kelsey R Thomas1, Emily C Edmonds1, Lisa Delano-Wood1, Mark W Bondi1.   

Abstract

OBJECTIVES: Within the Alzheimer's Disease Neuroimaging Initiative (ADNI)'s mild cognitive impairment (MCI) cohort, we previously identified MCI subtypes as well as participants initially diagnosed with MCI but found to have normal neuropsychological, biomarker, and neuroimaging profiles. We investigated the functional change over time in these empirically derived MCI subgroups.
METHODS: ADNI MCI participants (n=654) were classified using cluster analysis as Amnestic MCI (single-domain memory impairment), Dysnomic MCI (memory+language impairments), Dysexecutive/Mixed MCI (memory+language+attention/executive impairments), or Cluster-Derived Normal (CDN). Robust normal control participants (NCs; n=284) were also examined. The Functional Activities Questionnaire (FAQ) was administered at baseline through 48-month follow-up. Multilevel modeling examined FAQ trajectories by cognitive subgroup.
RESULTS: The Dysexecutive/Mixed group demonstrated the fastest rate of decline across all groups. Amnestic and Dysnomic groups showed steeper rates of decline than CDNs. While CDNs had more functional difficulty than NCs across visits, both groups' mean FAQ scores remained below its suggested cutoff at all visits.
CONCLUSIONS: Results (a) show the importance of executive dysfunction in the context of other impaired cognitive domains when predicting functional decline in at-risk elders, and (b) support our previous work demonstrating that ADNI's MCI criteria may have resulted in false-positive MCI diagnoses, given the CDN's better FAQ trajectory than those of the cognitively impaired MCI groups. (JINS, 2017, 23, 521-527).

Entities:  

Keywords:  Alzheimer’s disease; Dementia; Executive functioning; Functional activities questionnaire; Instrumental activities of daily living; MCI; longitudinal

Mesh:

Year:  2017        PMID: 28487004      PMCID: PMC5524519          DOI: 10.1017/S1355617717000285

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  22 in total

1.  Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.

Authors:  Emily C Edmonds; Lisa Delano-Wood; Lindsay R Clark; Amy J Jak; Daniel A Nation; Carrie R McDonald; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2014-05-22       Impact factor: 21.566

2.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

Review 3.  An examination of instrumental activities of daily living assessment in older adults and mild cognitive impairment.

Authors:  David A Gold
Journal:  J Clin Exp Neuropsychol       Date:  2011-11-04       Impact factor: 2.475

4.  Measurement of functional activities in older adults in the community.

Authors:  R I Pfeffer; T T Kurosaki; C H Harrah; J M Chance; S Filos
Journal:  J Gerontol       Date:  1982-05

5.  Mild cognitive impairment and everyday functioning in older adults.

Authors:  Holly Tuokko; Carolyn Morris; Patricia Ebert
Journal:  Neurocase       Date:  2005-02       Impact factor: 0.881

6.  Assessment of functional change and cognitive correlates in the progression from healthy cognitive aging to dementia.

Authors:  Maureen Schmitter-Edgecombe; Carolyn M Parsey
Journal:  Neuropsychology       Date:  2014-06-16       Impact factor: 3.295

7.  Changes in everyday function in individuals with psychometrically defined mild cognitive impairment in the Advanced Cognitive Training for Independent and Vital Elderly Study.

Authors:  Virginia G Wadley; Michael Crowe; Michael Marsiske; Sarah E Cook; Frederick W Unverzagt; Adrienne L Rosenberg; Daniel Rexroth
Journal:  J Am Geriatr Soc       Date:  2007-08       Impact factor: 5.562

8.  Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.

Authors:  Katherine J Bangen; Alexandra L Clark; Madeline Werhane; Emily C Edmonds; Daniel A Nation; Nicole Evangelista; David J Libon; Mark W Bondi; Lisa Delano-Wood
Journal:  J Alzheimers Dis       Date:  2016-03-29       Impact factor: 4.472

9.  Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria.

Authors:  Emily C Edmonds; Joel Eppig; Mark W Bondi; Kelly M Leyden; Bailey Goodwin; Lisa Delano-Wood; Carrie R McDonald
Journal:  Neurology       Date:  2016-10-19       Impact factor: 9.910

10.  Examination of Variables That May Affect the Relationship Between Cognition and Functional Status in Individuals with Mild Cognitive Impairment: A Meta-Analysis.

Authors:  Courtney Mcalister; Maureen Schmitter-Edgecombe; Richard Lamb
Journal:  Arch Clin Neuropsychol       Date:  2016-01-06       Impact factor: 2.813

View more
  18 in total

1.  Increasing Inaccuracy of Self-Reported Subjective Cognitive Complaints Over 24 Months in Empirically Derived Subtypes of Mild Cognitive Impairment.

Authors:  Emily C Edmonds; Alexandra J Weigand; Kelsey R Thomas; Joel Eppig; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2018-09       Impact factor: 2.892

2.  Early versus late MCI: Improved MCI staging using a neuropsychological approach.

Authors:  Emily C Edmonds; Carrie R McDonald; Anisa Marshall; Kelsey R Thomas; Joel Eppig; Alexandra J Weigand; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2019-02-06       Impact factor: 21.566

3.  Assessing Working Memory in Mild Cognitive Impairment with Serial Order Recall.

Authors:  Sheina Emrani; David J Libon; Melissa Lamar; Catherine C Price; Angela L Jefferson; Katherine A Gifford; Timothy J Hohman; Daniel A Nation; Lisa Delano-Wood; Amy Jak; Katherine J Bangen; Mark W Bondi; Adam M Brickman; Jennifer Manly; Rodney Swenson; Rhoda Au
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

4.  Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Kelsey R Thomas; Joel S Eppig; Alexandra J Weigand; Emily C Edmonds; Christina G Wong; Amy J Jak; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Steven D Edland; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2019-01-11       Impact factor: 21.566

5.  Regional hyperperfusion in older adults with objectively-defined subtle cognitive decline.

Authors:  Kelsey R Thomas; Jessica R Osuna; Alexandra J Weigand; Emily C Edmonds; Alexandra L Clark; Sophia Holmqvist; Isabel H Cota; Christina E Wierenga; Mark W Bondi; Katherine J Bangen
Journal:  J Cereb Blood Flow Metab       Date:  2020-07-02       Impact factor: 6.200

6.  Type 2 Diabetes Interacts With Alzheimer Disease Risk Factors to Predict Functional Decline.

Authors:  Kelsey R Thomas; Katherine J Bangen; Alexandra J Weigand; Emily C Edmonds; Erin Sundermann; Christina G Wong; Joel Eppig; Madeleine L Werhane; Lisa Delano-Wood; Mark W Bondi
Journal:  Alzheimer Dis Assoc Disord       Date:  2020 Jan-Mar       Impact factor: 2.703

7.  MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Kelsey R Thomas; Emily C Edmonds; Joel S Eppig; Christina G Wong; Alexandra J Weigand; Katherine J Bangen; Amy J Jak; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Steven D Edland; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2019-09-05       Impact factor: 21.566

8.  Pattern of regional white matter hyperintensity volume in mild cognitive impairment subtypes and associations with decline in daily functioning.

Authors:  Katherine J Bangen; Kelsey R Thomas; Alexandra J Weigand; Danielle L Sanchez; Lisa Delano-Wood; Emily C Edmonds; Owen T Carmichael; Christopher G Schwarz; Adam M Brickman; Mark W Bondi
Journal:  Neurobiol Aging       Date:  2019-11-02       Impact factor: 4.673

9.  Examining differences in neuropsychiatric symptom factor trajectories in empirically derived mild cognitive impairment subtypes.

Authors:  Alyssa N De Vito; Matthew Calamia; Daniel S Weitzner; John P K Bernstein
Journal:  Int J Geriatr Psychiatry       Date:  2018-10-01       Impact factor: 3.485

10.  Patterns of longitudinal cortical atrophy over 3 years in empirically derived MCI subtypes.

Authors:  Emily C Edmonds; Alexandra J Weigand; Sean N Hatton; Anisa J Marshall; Kelsey R Thomas; Daniela A Ayala; Mark W Bondi; Carrie R McDonald
Journal:  Neurology       Date:  2020-05-11       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.